ABBOTT LABORATORIES LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

Ernst & Young

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Company generated a net profit of £256,187,000 (2023: £179,615,000), has net assets of £871,804,000 (2023: £767,315,000) and current assets of the Company exceed its current liabilities by £37,218,000 (2023: £33,364,000). Trading profits are expected to continue in the foreseeable future. Therefore, after making enquiries, the Directors have a reasonable expectation that the Company will continue in operational existence for a period of twelve months from the date of approval of the financial statements. Accordingly, the Directors continue to adopt the going concern basis of accounting in preparing the annual report and financial statements.”

Group structure

1. ABBOTT LABORATORIES LIMITED · parent
   1. Abbott Diabetes Care Limited 100% · England and Wales · Contract manufacturer of biosensor strips and licensee of technology, engaged in the manufacture and sale of biosensing products
   2. Murex Biotech Limited 100% · England and Wales · Intra group lending
   3. Abbott Laboratories Trustee Company 100% · England and Wales · Acting as a pension trustee
   4. Abbott Medical UK Limited 100% · England and Wales · Marketing, distribution and sale of medical devices in the UK
   5. Abbott (UK) Finance Limited 100% · England and Wales · Finance company to other Abbott group companies
   6. Lingo Technology UK Limited 100% · England and Wales · Provision of marketing support to other Abbott group companies

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

5

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +18.6%

  £539,543,000 → £639,882,000

• Cash

  +25.5%

  £5,269,000 → £6,614,000

• Net assets

  +13.6%

  £767,315,000 → £871,804,000

• Employees

  +2.5%

  566 → 580

• Operating profit

  +15%

  £16,723,000 → £19,238,000

• Profit before tax

  +40.2%

  £190,175,000 → £266,562,000

• Wages

  +3.5%

  £49,993,000 → £51,742,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers